Rebecca Nuzzo

Rebecca Nuzzo has over 19 years of experience in the pharmaceutical and clinical research industry. Their most recent role is Director of Clinical Operations Lead at Upstream Bio since August 2023. Prior to that, they worked at Biogen as an Associate Director of Clinical Trial Lead from March 2022 to July 2023. Rebecca also served as Director of Clinical Operations Program Lead at Dyne Therapeutics from July 2021 to March 2022. Rebecca has held various positions at Biogen, including Associate Director of Clinical Operations Study Lead from April 2018 to July 2021. Rebecca's experience also includes roles at Shire as a Senior Clinical Project Manager from October 2016 to March 2018, Takeda Pharmaceuticals as a Clinical Study Manager from October 2012 to September 2016, and Clinical Assistance Programs as a CRA from September 2011 to September 2012. Rebecca started their career as a CRA at Predictive Biosciences from 2008 to 2011, then at BattelleCRO from 2005 to 2008. Rebecca began their career as a Clinical Research Coordinator at Massachusetts General Hospital in 2004.

Rebecca Nuzzo attended the University of Michigan from 1997 to 2001. However, there is no information available regarding the degree they pursued or the specific field of study they focused on during their time at the university.